GLOBAL CORD BLOOD CORP (CORBF) is held by institutional investors who disclose positions via SEC 13F filings. View the full list of institutional holders on HoldingsIntel.

Are institutions buying or selling CORBF?

HoldingsIntel tracks quarter-over-quarter changes in institutional positions for GLOBAL CORD BLOOD CORP, showing new buyers, position increases, decreases, and exits with conviction-weighted sentiment.

What is the Smart Money Verdict on CORBF?

The Smart Money Verdict combines four independent signals (institutional 13F activity, insider trades, activist filings, and congressional trades) into a single assessment for GLOBAL CORD BLOOD CORP.

Is institutional money flowing into CORBF?

1 institutional investors hold GLOBAL CORD BLOOD CORP (CORBF). View detailed buyer/seller breakdown on HoldingsIntel.

What do hedge funds think about CORBF?

Track institutional sentiment and conviction scores for GLOBAL CORD BLOOD CORP (CORBF) including Smart Money Verdict and position changes on HoldingsIntel.

GLOBAL CORD BLOOD CORP

CORBF·G39342103·US·equity·Healthcare - Diagnostics & Research-13D/G

Holders

Avg rating

$14,030

Total Value

—

Fund Consensus

Smart Money Verdict

No institutional consensus yet

Fewer than 2 tracked funds currently hold CORBF (GLOBAL CORD BLOOD CORP). We surface convergence signals once 2+ institutional funds, insiders, or activists take a position.

This is the correct empty state for thinly-held stocks, not a data issue. New 13F filings arrive quarterly; insider and activist filings update daily.

Explore stocks with active smart-money signals →

13F: Mar 31, 2026Insider & Congress: Updated regularly

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
RHUMBLINE ADVISERS	Unchanged	13,362	$14,030	0.0%	-12.37%	0

Continue exploring

Smart money flow

Track where institutional capital is flowing

Discover new institutional entries

Fresh positions initiated this quarter

Check sector trends

Capital flows across GICS sectors

Other Healthcare stocks held by institutions

LLYELI LILLY & CO

410 holders · $577.8B

UNHUNITEDHEALTH GROUP INC

409 holders · $155.8B

JNJJOHNSON & JOHNSON

391 holders · $327.3B

DHRDANAHER CORP DEL

388 holders · $82.5B

ISRGINTUITIVE SURGICAL INC

388 holders · $102.1B

TMOTHERMO FISHER SCIENTIFIC INC

387 holders · $127.1B

BSXBOSTON SCIENTIFIC CORP

386 holders · $67.5B

MRKMERCK & CO INC

381 holders · $175.6B

ABBVABBVIE INC

378 holders · $212.3B

ABTABBOTT LABORATORIES

376 holders · $108.9B

High Conviction Moves-Signal Convergence-Fund Consensus-Double-Down Signals

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer